Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.813 | 2.82e-15 | 6.25e-04 | 4.06e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
EIF2S2 | 8894 | 9 | -2.999 | 2.968 | 81 | Yes | Yes |
PHB2 | 11331 | 5 | -2.236 | 2.994 | 140 | Yes | - |
[ SCN8A ] | 6334 | 1 | -1.173 | 2.813 | 5 | - | - |
PHB | 5245 | 15 | -2.743 | 3.004 | 127 | Yes | Yes |
ICT1 | 3396 | 2 | -2.210 | 2.813 | 208 | Yes | - |
TADA2B | 93624 | 11 | -3.061 | 3.082 | 19 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
EIF2B2 | 8892 | 8 | -2.462 | 2.968 | 95 | Yes | Yes |
APC | 324 | 13 | -2.293 | 3.004 | 353 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
GSTP1 | 2950 | 3 | -2.251 | 2.955 | 59 | Yes | - |
MAPK14 | 1432 | 4 | -1.902 | 2.955 | 272 | - | - |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
FUBP1 | 8880 | 3 | -2.414 | 2.955 | 23 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
EIF2B2 | 8892 | TADA2B | 93624 | pp | -- | int.I2D: BioGrid_Fly, BIND_Fly, FlyLow, IntAct_Fly, MINT_Fly |
ICT1 | 3396 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid |
MAPK14 | 1432 | DDIT3 | 1649 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro |
PHB | 5245 | SCN8A | 6334 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
MAPK14 | 1432 | FUBP1 | 8880 | pp | -- | int.I2D: BioGrid |
PHB | 5245 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast |
MAPK14 | 1432 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
PSMD2 | 5708 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct_Yeast |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
APC | 324 | PHB | 5245 | pp | -- | int.I2D: Jorgensen_EphR |
DDIT3 | 1649 | GSTP1 | 2950 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
ICT1 | 3396 | PHB | 5245 | pp | -- | int.I2D: BioGrid |
EIF2B2 | 8892 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh |
MAPK14 | 1432 | GSTP1 | 2950 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BCI |
MAPK14 | 1432 | SCN8A | 6334 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0044212 | transcription regulatory region DNA binding | 2.90e-05 | 4.18e-01 | 4.424 | 4 | 17 | 168 |
GO:0010467 | gene expression | 5.23e-05 | 7.54e-01 | 3.015 | 6 | 45 | 669 |
GO:0005654 | nucleoplasm | 8.21e-05 | 1.00e+00 | 2.544 | 7 | 64 | 1082 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 8.94e-05 | 1.00e+00 | 7.116 | 2 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 8.94e-05 | 1.00e+00 | 7.116 | 2 | 2 | 13 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.08e-04 | 1.00e+00 | 4.975 | 3 | 8 | 86 |
GO:0005829 | cytosol | 4.86e-04 | 1.00e+00 | 1.701 | 9 | 86 | 2496 |
GO:0006974 | cellular response to DNA damage stimulus | 5.70e-04 | 1.00e+00 | 4.163 | 3 | 7 | 151 |
GO:0042552 | myelination | 6.72e-04 | 1.00e+00 | 5.687 | 2 | 4 | 35 |
GO:0035019 | somatic stem cell maintenance | 8.78e-04 | 1.00e+00 | 5.494 | 2 | 6 | 40 |
GO:0070664 | negative regulation of leukocyte proliferation | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0070126 | mitochondrial translational termination | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0035732 | nitric oxide storage | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0097057 | TRAF2-GSTP1 complex | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0070026 | nitric oxide binding | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0035731 | dinitrosyl-iron complex binding | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0016150 | translation release factor activity, codon nonspecific | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0035730 | S-nitrosoglutathione binding | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0003743 | translation initiation factor activity | 1.32e-03 | 1.00e+00 | 5.201 | 2 | 7 | 49 |
GO:0005515 | protein binding | 1.51e-03 | 1.00e+00 | 0.960 | 13 | 198 | 6024 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0009890 | negative regulation of biosynthetic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0019207 | kinase regulator activity | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0009798 | axis specification | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0035726 | common myeloid progenitor cell proliferation | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0090400 | stress-induced premature senescence | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0004045 | aminoacyl-tRNA hydrolase activity | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0071222 | cellular response to lipopolysaccharide | 3.55e-03 | 1.00e+00 | 4.476 | 2 | 4 | 81 |
GO:0006355 | regulation of transcription, DNA-templated | 3.59e-03 | 1.00e+00 | 2.177 | 5 | 43 | 997 |
GO:0005739 | mitochondrion | 3.60e-03 | 1.00e+00 | 2.175 | 5 | 23 | 998 |
GO:0051716 | cellular response to stimulus | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 4 | 4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 4 |
GO:0046523 | S-methyl-5-thioribose-1-phosphate isomerase activity | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 3 | 4 |
GO:0019887 | protein kinase regulator activity | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 4 |
GO:0001649 | osteoblast differentiation | 4.56e-03 | 1.00e+00 | 4.293 | 2 | 5 | 92 |
GO:0007417 | central nervous system development | 4.95e-03 | 1.00e+00 | 4.231 | 2 | 5 | 96 |
GO:0070461 | SAGA-type complex | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 2 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 2 | 5 |
GO:0051525 | NFAT protein binding | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 2 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:0030858 | positive regulation of epithelial cell differentiation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 6 |
GO:0032691 | negative regulation of interleukin-1 beta production | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 6 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 4 | 6 |
GO:0008432 | JUN kinase binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 6 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 7 |
GO:0071354 | cellular response to interleukin-6 | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 7 |
GO:0032930 | positive regulation of superoxide anion generation | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 7 |
GO:0002674 | negative regulation of acute inflammatory response | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 7 |
GO:0007050 | cell cycle arrest | 8.13e-03 | 1.00e+00 | 3.862 | 2 | 5 | 124 |
GO:0032872 | regulation of stress-activated MAPK cascade | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 8 |
GO:0045670 | regulation of osteoclast differentiation | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 2 | 8 |
GO:0001955 | blood vessel maturation | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 8 |
GO:0010831 | positive regulation of myotube differentiation | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 8 |
GO:0006413 | translational initiation | 9.04e-03 | 1.00e+00 | 3.783 | 2 | 7 | 131 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 9.54e-03 | 1.00e+00 | 2.192 | 4 | 41 | 789 |
GO:0045892 | negative regulation of transcription, DNA-templated | 9.89e-03 | 1.00e+00 | 2.711 | 3 | 24 | 413 |
GO:0045667 | regulation of osteoblast differentiation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 9 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 9 |
GO:0000302 | response to reactive oxygen species | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 9 |
GO:0019509 | L-methionine biosynthetic process from methylthioadenosine | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 3 | 9 |
GO:0006983 | ER overload response | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 9 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 9 |
GO:0032495 | response to muramyl dipeptide | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 9 |
GO:0005634 | nucleus | 1.06e-02 | 1.00e+00 | 0.984 | 10 | 159 | 4559 |
GO:0043194 | axon initial segment | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 2 | 10 |
GO:0001518 | voltage-gated sodium channel complex | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 2 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 2 | 10 |
GO:0030877 | beta-catenin destruction complex | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 2 | 10 |
GO:0042981 | regulation of apoptotic process | 1.17e-02 | 1.00e+00 | 3.587 | 2 | 4 | 150 |
GO:0045663 | positive regulation of myoblast differentiation | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 11 |
GO:0051010 | microtubule plus-end binding | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 3 | 11 |
GO:0019395 | fatty acid oxidation | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 11 |
GO:0004707 | MAP kinase activity | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 11 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 11 |
GO:0032886 | regulation of microtubule-based process | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0045295 | gamma-catenin binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0050905 | neuromuscular process | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0043508 | negative regulation of JUN kinase activity | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 13 |
GO:0071480 | cellular response to gamma radiation | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 13 |
GO:0004708 | MAP kinase kinase activity | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 13 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 3 | 13 |
GO:0044295 | axonal growth cone | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 13 |
GO:0030914 | STAGA complex | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 3 | 13 |
GO:0030234 | enzyme regulator activity | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 13 |
GO:0044267 | cellular protein metabolic process | 1.44e-02 | 1.00e+00 | 2.512 | 3 | 20 | 474 |
GO:0035371 | microtubule plus-end | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 14 |
GO:0005762 | mitochondrial large ribosomal subunit | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 14 |
GO:0003714 | transcription corepressor activity | 1.62e-02 | 1.00e+00 | 3.340 | 2 | 11 | 178 |
GO:0042307 | positive regulation of protein import into nucleus | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 4 | 15 |
GO:0001824 | blastocyst development | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 15 |
GO:0060749 | mammary gland alveolus development | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 15 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 1 | 16 |
GO:0033268 | node of Ranvier | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 2 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 2 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 2 | 16 |
GO:0005248 | voltage-gated sodium channel activity | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 1 | 16 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 2 | 17 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 17 |
GO:0019228 | neuronal action potential | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 18 |
GO:0031122 | cytoplasmic microtubule organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 18 |
GO:0004364 | glutathione transferase activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 18 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 19 |
GO:0006915 | apoptotic process | 2.18e-02 | 1.00e+00 | 2.285 | 3 | 12 | 555 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 20 |
GO:0001502 | cartilage condensation | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 20 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 20 |
GO:1901687 | glutathione derivative biosynthetic process | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 20 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 3 | 20 |
GO:0014003 | oligodendrocyte development | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 5 | 20 |
GO:0045648 | positive regulation of erythrocyte differentiation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 21 |
GO:0000281 | mitotic cytokinesis | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 2 | 21 |
GO:0030316 | osteoclast differentiation | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 22 |
GO:0048147 | negative regulation of fibroblast proliferation | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 4 | 22 |
GO:0016071 | mRNA metabolic process | 2.48e-02 | 1.00e+00 | 3.015 | 2 | 8 | 223 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 1 | 23 |
GO:0071479 | cellular response to ionizing radiation | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 1 | 23 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 2 | 23 |
GO:0044822 | poly(A) RNA binding | 2.56e-02 | 1.00e+00 | 1.772 | 4 | 50 | 1056 |
GO:0006412 | translation | 2.62e-02 | 1.00e+00 | 2.971 | 2 | 8 | 230 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 3 | 24 |
GO:0045296 | cadherin binding | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 3 | 24 |
GO:0007422 | peripheral nervous system development | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 2 | 25 |
GO:0086010 | membrane depolarization during action potential | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 2 | 25 |
GO:0035329 | hippo signaling | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 1 | 26 |
GO:0008134 | transcription factor binding | 2.88e-02 | 1.00e+00 | 2.897 | 2 | 18 | 242 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 4 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 27 |
GO:0000077 | DNA damage checkpoint | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 1 | 27 |
GO:0030331 | estrogen receptor binding | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 27 |
GO:0006749 | glutathione metabolic process | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 1 | 27 |
GO:0016070 | RNA metabolic process | 2.99e-02 | 1.00e+00 | 2.868 | 2 | 8 | 247 |
GO:0007628 | adult walking behavior | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 3 | 28 |
GO:0071897 | DNA biosynthetic process | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 1 | 28 |
GO:0070830 | tight junction assembly | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 1 | 28 |
GO:0005913 | cell-cell adherens junction | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 3 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 2 | 29 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 30 |
GO:0009953 | dorsal/ventral pattern formation | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 2 | 31 |
GO:0042594 | response to starvation | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 4 | 31 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 1 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 3 | 31 |
GO:0043407 | negative regulation of MAP kinase activity | 3.49e-02 | 1.00e+00 | 4.816 | 1 | 1 | 32 |
GO:0002062 | chondrocyte differentiation | 3.49e-02 | 1.00e+00 | 4.816 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.49e-02 | 1.00e+00 | 4.816 | 1 | 2 | 32 |
GO:0033077 | T cell differentiation in thymus | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 1 | 33 |
GO:0005743 | mitochondrial inner membrane | 3.69e-02 | 1.00e+00 | 2.702 | 2 | 6 | 277 |
GO:0042692 | muscle cell differentiation | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 4 | 34 |
GO:0001942 | hair follicle development | 3.81e-02 | 1.00e+00 | 4.687 | 1 | 2 | 35 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 3.81e-02 | 1.00e+00 | 4.687 | 1 | 2 | 35 |
GO:0048538 | thymus development | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 36 |
GO:0006446 | regulation of translational initiation | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 4 | 36 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.96e-02 | 1.00e+00 | 1.952 | 3 | 39 | 699 |
GO:0001541 | ovarian follicle development | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 2 | 37 |
GO:0003677 | DNA binding | 4.05e-02 | 1.00e+00 | 1.566 | 4 | 49 | 1218 |
GO:0051781 | positive regulation of cell division | 4.24e-02 | 1.00e+00 | 4.531 | 1 | 1 | 39 |
GO:0005881 | cytoplasmic microtubule | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 1 | 40 |
GO:0045785 | positive regulation of cell adhesion | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 2 | 40 |
GO:0009408 | response to heat | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 6 | 40 |
GO:0007519 | skeletal muscle tissue development | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 2 | 40 |
GO:0043434 | response to peptide hormone | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 5 | 45 |
GO:0005524 | ATP binding | 4.95e-02 | 1.00e+00 | 1.474 | 4 | 31 | 1298 |
GO:0016328 | lateral plasma membrane | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 3 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 4 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 2 | 47 |
GO:0006814 | sodium ion transport | 5.30e-02 | 1.00e+00 | 4.201 | 1 | 1 | 49 |
GO:0000902 | cell morphogenesis | 5.30e-02 | 1.00e+00 | 4.201 | 1 | 4 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 4 | 50 |
GO:0003723 | RNA binding | 5.41e-02 | 1.00e+00 | 2.398 | 2 | 18 | 342 |
GO:0045732 | positive regulation of protein catabolic process | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 1 | 50 |
GO:0060041 | retina development in camera-type eye | 5.51e-02 | 1.00e+00 | 4.144 | 1 | 2 | 51 |
GO:0034976 | response to endoplasmic reticulum stress | 5.51e-02 | 1.00e+00 | 4.144 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 5.51e-02 | 1.00e+00 | 4.144 | 1 | 1 | 51 |
GO:0043565 | sequence-specific DNA binding | 5.52e-02 | 1.00e+00 | 2.381 | 2 | 11 | 346 |
GO:0009611 | response to wounding | 5.62e-02 | 1.00e+00 | 4.116 | 1 | 5 | 52 |
GO:0035725 | sodium ion transmembrane transport | 5.62e-02 | 1.00e+00 | 4.116 | 1 | 1 | 52 |
GO:0008285 | negative regulation of cell proliferation | 5.72e-02 | 1.00e+00 | 2.353 | 2 | 10 | 353 |
GO:0051403 | stress-activated MAPK cascade | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 2 | 54 |
GO:0000502 | proteasome complex | 6.25e-02 | 1.00e+00 | 3.958 | 1 | 3 | 58 |
GO:0006396 | RNA processing | 6.35e-02 | 1.00e+00 | 3.933 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 6.35e-02 | 1.00e+00 | 3.933 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 9 | 60 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 6.56e-02 | 1.00e+00 | 3.885 | 1 | 2 | 61 |
GO:0000776 | kinetochore | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 5 | 63 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.87e-02 | 1.00e+00 | 3.816 | 1 | 1 | 64 |
GO:0009749 | response to glucose | 6.87e-02 | 1.00e+00 | 3.816 | 1 | 7 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 2 | 65 |
GO:0009636 | response to toxic substance | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 1 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 4 | 65 |
GO:0007409 | axonogenesis | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 2 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 4 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 4 | 65 |
GO:0003697 | single-stranded DNA binding | 7.29e-02 | 1.00e+00 | 3.729 | 1 | 5 | 68 |
GO:0010468 | regulation of gene expression | 7.29e-02 | 1.00e+00 | 3.729 | 1 | 2 | 68 |
GO:0018105 | peptidyl-serine phosphorylation | 7.39e-02 | 1.00e+00 | 3.708 | 1 | 2 | 69 |
GO:0032587 | ruffle membrane | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 3 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 2 | 70 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 7.60e-02 | 1.00e+00 | 3.666 | 1 | 5 | 71 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 7.60e-02 | 1.00e+00 | 3.666 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 7.60e-02 | 1.00e+00 | 3.666 | 1 | 4 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 4 | 72 |
GO:0042826 | histone deacetylase binding | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 1 | 72 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.73e-02 | 1.00e+00 | 2.105 | 2 | 30 | 419 |
GO:0034134 | toll-like receptor 2 signaling pathway | 7.80e-02 | 1.00e+00 | 3.626 | 1 | 4 | 73 |
GO:0043066 | negative regulation of apoptotic process | 7.89e-02 | 1.00e+00 | 2.088 | 2 | 16 | 424 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 7.90e-02 | 1.00e+00 | 3.607 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.90e-02 | 1.00e+00 | 3.607 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 8.01e-02 | 1.00e+00 | 3.587 | 1 | 1 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 8.01e-02 | 1.00e+00 | 3.587 | 1 | 4 | 75 |
GO:0008584 | male gonad development | 8.01e-02 | 1.00e+00 | 3.587 | 1 | 3 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.01e-02 | 1.00e+00 | 3.587 | 1 | 1 | 75 |
GO:0007265 | Ras protein signal transduction | 8.01e-02 | 1.00e+00 | 3.587 | 1 | 3 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 8.11e-02 | 1.00e+00 | 3.568 | 1 | 3 | 76 |
GO:0001822 | kidney development | 8.31e-02 | 1.00e+00 | 3.531 | 1 | 3 | 78 |
GO:0071013 | catalytic step 2 spliceosome | 8.31e-02 | 1.00e+00 | 3.531 | 1 | 7 | 78 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 8.31e-02 | 1.00e+00 | 3.531 | 1 | 3 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 8.42e-02 | 1.00e+00 | 3.512 | 1 | 3 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 8.42e-02 | 1.00e+00 | 3.512 | 1 | 2 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.42e-02 | 1.00e+00 | 3.512 | 1 | 2 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 8.52e-02 | 1.00e+00 | 3.494 | 1 | 5 | 80 |
GO:0009653 | anatomical structure morphogenesis | 8.82e-02 | 1.00e+00 | 3.441 | 1 | 2 | 83 |
GO:0007517 | muscle organ development | 8.82e-02 | 1.00e+00 | 3.441 | 1 | 4 | 83 |
GO:0009952 | anterior/posterior pattern specification | 8.82e-02 | 1.00e+00 | 3.441 | 1 | 4 | 83 |
GO:0005923 | tight junction | 9.13e-02 | 1.00e+00 | 3.390 | 1 | 2 | 86 |
GO:0000922 | spindle pole | 9.23e-02 | 1.00e+00 | 3.373 | 1 | 4 | 87 |
GO:0000187 | activation of MAPK activity | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 3 | 90 |
GO:0016363 | nuclear matrix | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 6 | 91 |
GO:0006928 | cellular component movement | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 3 | 91 |
GO:0045893 | positive regulation of transcription, DNA-templated | 9.69e-02 | 1.00e+00 | 1.915 | 2 | 24 | 478 |
GO:0005737 | cytoplasm | 9.70e-02 | 1.00e+00 | 0.744 | 7 | 124 | 3767 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 9.74e-02 | 1.00e+00 | 3.293 | 1 | 1 | 92 |
GO:0005770 | late endosome | 9.84e-02 | 1.00e+00 | 3.277 | 1 | 2 | 93 |
GO:0034142 | toll-like receptor 4 signaling pathway | 1.01e-01 | 1.00e+00 | 3.231 | 1 | 4 | 96 |
GO:0030018 | Z disc | 1.02e-01 | 1.00e+00 | 3.216 | 1 | 4 | 97 |
GO:0034765 | regulation of ion transmembrane transport | 1.03e-01 | 1.00e+00 | 3.201 | 1 | 2 | 98 |
GO:0006805 | xenobiotic metabolic process | 1.08e-01 | 1.00e+00 | 3.130 | 1 | 2 | 103 |
GO:0007605 | sensory perception of sound | 1.09e-01 | 1.00e+00 | 3.116 | 1 | 2 | 104 |
GO:0006935 | chemotaxis | 1.10e-01 | 1.00e+00 | 3.102 | 1 | 3 | 105 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 1.10e-01 | 1.00e+00 | 3.102 | 1 | 8 | 105 |
GO:0070062 | extracellular vesicular exosome | 1.13e-01 | 1.00e+00 | 0.909 | 5 | 57 | 2400 |
GO:0002224 | toll-like receptor signaling pathway | 1.14e-01 | 1.00e+00 | 3.048 | 1 | 4 | 109 |
GO:0030308 | negative regulation of cell growth | 1.15e-01 | 1.00e+00 | 3.035 | 1 | 6 | 110 |
GO:0006461 | protein complex assembly | 1.16e-01 | 1.00e+00 | 3.022 | 1 | 4 | 111 |
GO:0030529 | ribonucleoprotein complex | 1.17e-01 | 1.00e+00 | 3.009 | 1 | 5 | 112 |
GO:0000209 | protein polyubiquitination | 1.21e-01 | 1.00e+00 | 2.958 | 1 | 3 | 116 |
GO:0006006 | glucose metabolic process | 1.23e-01 | 1.00e+00 | 2.933 | 1 | 5 | 118 |
GO:0006325 | chromatin organization | 1.23e-01 | 1.00e+00 | 2.933 | 1 | 12 | 118 |
GO:0030027 | lamellipodium | 1.30e-01 | 1.00e+00 | 2.850 | 1 | 7 | 125 |
GO:0030335 | positive regulation of cell migration | 1.32e-01 | 1.00e+00 | 2.827 | 1 | 5 | 127 |
GO:0016477 | cell migration | 1.33e-01 | 1.00e+00 | 2.816 | 1 | 4 | 128 |
GO:0031982 | vesicle | 1.36e-01 | 1.00e+00 | 2.783 | 1 | 3 | 131 |
GO:0016055 | Wnt signaling pathway | 1.43e-01 | 1.00e+00 | 2.708 | 1 | 4 | 138 |
GO:0010628 | positive regulation of gene expression | 1.50e-01 | 1.00e+00 | 2.626 | 1 | 7 | 146 |
GO:0008017 | microtubule binding | 1.51e-01 | 1.00e+00 | 2.616 | 1 | 2 | 147 |
GO:0007166 | cell surface receptor signaling pathway | 1.51e-01 | 1.00e+00 | 2.616 | 1 | 4 | 147 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 3 | 149 |
GO:0000398 | mRNA splicing, via spliceosome | 1.67e-01 | 1.00e+00 | 2.459 | 1 | 15 | 164 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 1.78e-01 | 1.00e+00 | 2.365 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.80e-01 | 1.00e+00 | 2.340 | 1 | 5 | 178 |
GO:0043547 | positive regulation of GTPase activity | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 9 | 180 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.86e-01 | 1.00e+00 | 2.293 | 1 | 22 | 184 |
GO:0001525 | angiogenesis | 1.92e-01 | 1.00e+00 | 2.239 | 1 | 7 | 191 |
GO:0001701 | in utero embryonic development | 2.01e-01 | 1.00e+00 | 2.165 | 1 | 8 | 201 |
GO:0030168 | platelet activation | 2.05e-01 | 1.00e+00 | 2.137 | 1 | 6 | 205 |
GO:0005622 | intracellular | 2.07e-01 | 1.00e+00 | 2.123 | 1 | 6 | 207 |
GO:0006351 | transcription, DNA-templated | 2.12e-01 | 1.00e+00 | 0.903 | 3 | 57 | 1446 |
GO:0008380 | RNA splicing | 2.25e-01 | 1.00e+00 | 1.983 | 1 | 22 | 228 |
GO:0030425 | dendrite | 2.27e-01 | 1.00e+00 | 1.971 | 1 | 6 | 230 |
GO:0007399 | nervous system development | 2.28e-01 | 1.00e+00 | 1.964 | 1 | 6 | 231 |
GO:0003713 | transcription coactivator activity | 2.33e-01 | 1.00e+00 | 1.927 | 1 | 24 | 237 |
GO:0043025 | neuronal cell body | 2.40e-01 | 1.00e+00 | 1.879 | 1 | 9 | 245 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.56e-01 | 1.00e+00 | 1.772 | 1 | 23 | 264 |
GO:0043065 | positive regulation of apoptotic process | 2.59e-01 | 1.00e+00 | 1.750 | 1 | 7 | 268 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.60e-01 | 1.00e+00 | 1.745 | 1 | 7 | 269 |
GO:0007165 | signal transduction | 2.66e-01 | 1.00e+00 | 0.991 | 2 | 13 | 907 |
GO:0019899 | enzyme binding | 2.67e-01 | 1.00e+00 | 1.702 | 1 | 9 | 277 |
GO:0043234 | protein complex | 2.82e-01 | 1.00e+00 | 1.612 | 1 | 11 | 295 |
GO:0016020 | membrane | 2.84e-01 | 1.00e+00 | 0.686 | 3 | 46 | 1681 |
GO:0035556 | intracellular signal transduction | 2.88e-01 | 1.00e+00 | 1.573 | 1 | 9 | 303 |
GO:0004674 | protein serine/threonine kinase activity | 2.92e-01 | 1.00e+00 | 1.549 | 1 | 6 | 308 |
GO:0005525 | GTP binding | 2.94e-01 | 1.00e+00 | 1.540 | 1 | 12 | 310 |
GO:0019901 | protein kinase binding | 2.99e-01 | 1.00e+00 | 1.508 | 1 | 18 | 317 |
GO:0007411 | axon guidance | 3.01e-01 | 1.00e+00 | 1.499 | 1 | 5 | 319 |
GO:0005813 | centrosome | 3.06e-01 | 1.00e+00 | 1.467 | 1 | 7 | 326 |
GO:0003682 | chromatin binding | 3.07e-01 | 1.00e+00 | 1.463 | 1 | 19 | 327 |
GO:0008283 | cell proliferation | 3.08e-01 | 1.00e+00 | 1.459 | 1 | 14 | 328 |
GO:0007155 | cell adhesion | 3.40e-01 | 1.00e+00 | 1.289 | 1 | 5 | 369 |
GO:0046982 | protein heterodimerization activity | 3.48e-01 | 1.00e+00 | 1.246 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 3.56e-01 | 1.00e+00 | 1.205 | 1 | 15 | 391 |
GO:0009986 | cell surface | 3.64e-01 | 1.00e+00 | 1.165 | 1 | 9 | 402 |
GO:0044281 | small molecule metabolic process | 3.94e-01 | 1.00e+00 | 0.574 | 2 | 20 | 1211 |
GO:0007596 | blood coagulation | 4.01e-01 | 1.00e+00 | 0.986 | 1 | 11 | 455 |
GO:0016032 | viral process | 4.53e-01 | 1.00e+00 | 0.755 | 1 | 26 | 534 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.76e-01 | 1.00e+00 | 0.661 | 1 | 37 | 570 |
GO:0045087 | innate immune response | 4.91e-01 | 1.00e+00 | 0.597 | 1 | 15 | 596 |
GO:0005886 | plasma membrane | 5.66e-01 | 1.00e+00 | 0.067 | 3 | 49 | 2582 |
GO:0005887 | integral component of plasma membrane | 6.38e-01 | 1.00e+00 | 0.022 | 1 | 10 | 888 |
GO:0005615 | extracellular space | 6.67e-01 | 1.00e+00 | -0.086 | 1 | 20 | 957 |
GO:0008270 | zinc ion binding | 6.82e-01 | 1.00e+00 | -0.145 | 1 | 27 | 997 |
GO:0046872 | metal ion binding | 7.81e-01 | 1.00e+00 | -0.536 | 1 | 29 | 1307 |
GO:0005730 | nucleolus | 8.55e-01 | 1.00e+00 | -0.864 | 1 | 66 | 1641 |
GO:0016021 | integral component of membrane | 9.06e-01 | 1.00e+00 | -1.137 | 1 | 17 | 1982 |